Skip to main content
Caplight Logo









PainQx

PainQx

Private
New York City, New YorkHealthcare & Life Scienceshttps://painqx.com

Last Round

Series A

Aug 28, 2021

Total Funding Raised

$3.67M

Company Overview

PainQx is a digital health company that has developed an AI-powered platform for the objective, quantitative assessment of chronic pain using EEG data.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical Devices, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

pain assessmentEEGelectroencephalographyclinical decision supportdigital healthpain biomarkermedical AIclinical trialsobjective pain measurementpain managementdiagnostic softwarehealthcare analyticsdigital biomarkermedtechhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PainQx Comparables

Compare PainQx with similar companies based on industry and business-model similarity.

PainQx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioTraceIT
81%
PaMeLa, Inc.
80%
AlgometRx, Inc.
74%

PainQx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 28, 2021
GrantJun 9, 2021
GrantSep 24, 2019
SeedAug 28, 2017

PainQx Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 28, 2021

    Completed a Series A funding round.

  • Jun 9, 2021

    $1.5M grant awarded by the Defense Health Agency.

PainQx Filings

Explore SEC and related filing metadata, where available.

PainQx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PainQx's valuation, stock price, and market status.

Is PainQx a public or private company?

PainQx is a private company.

What is the current stock price of PainQx?

PainQx is a private company with no public stock price. Caplight tracks PainQx's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is PainQx worth (valuation)?

Valuation information for PainQx is not publicly available.

Can I buy PainQx stock?

PainQx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PainQx's last funding round?

PainQx's most recent funding round was Series A on August 28, 2021.

Who are the main investors in PainQx?

Key investors in PainQx include National Institute on Drug Abuse, Defense Health Agency, Arizona Tech Investors, Accelerate Long Island, MABA.

Will PainQx IPO soon?

No public IPO plans have been announced for PainQx.

How can I track PainQx secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PainQx's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range5
Year Founded2015
Last FundingAug 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?